The Open UniversitySkip to content
 

EZH2 and cancer stem cells: fact or fiction?

Crea, Francesco (2011). EZH2 and cancer stem cells: fact or fiction? Epigenomics, 3(2) pp. 127–128.

DOI (Digital Object Identifier) Link: https://doi.org/10.2217/EPI.11.4
Google Scholar: Look up in Google Scholar

Abstract

Several recent publications have shed new light on the role of epigenetic modifications in cancer stem cell (CSC) biology. Among other epigenetic players, polycomb group genes appear to be particularly attractive. Indeed, they are emerging as CSC-specific markers, as well as potential targets for cancer therapy. However, before these discoveries can be applied to the clinical setting, the specific role of polycomb group genes in CSC tumorigenic activity should be explained further.

Item Type: Journal Item
Copyright Holders: 2011 Future Medicine Ltd
ISSN: 1750-192X
Keywords: cancer stem cells; cell culture; EZH2; polycomb; serum
Academic Unit/School: Faculty of Science, Technology, Engineering and Mathematics (STEM) > Life, Health and Chemical Sciences
Faculty of Science, Technology, Engineering and Mathematics (STEM)
Item ID: 45822
Depositing User: Francesco Crea
Date Deposited: 16 May 2016 08:49
Last Modified: 07 Dec 2018 10:39
URI: http://oro.open.ac.uk/id/eprint/45822
Share this page:

Metrics

Altmetrics from Altmetric

Citations from Dimensions

Actions (login may be required)

Policies | Disclaimer

© The Open University   contact the OU